Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash & Equivalents (2020 - 2025)

Beauty Health (SKIN) has disclosed Cash & Equivalents for 6 consecutive years, with $232.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 37.13% to $232.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $232.7 million through Dec 2025, down 37.13% year-over-year, with the annual reading at $232.7 million for FY2025, 37.13% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $232.7 million at Beauty Health, up from $219.4 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $901.9 million in Q4 2021, with the low at $2.8 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $469.1 million, with a median of $483.8 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents soared 2874388.0% in 2021, then plummeted 39.35% in 2025.
  • Over 5 years, Cash & Equivalents stood at $901.9 million in 2021, then plummeted by 37.0% to $568.2 million in 2022, then decreased by 7.95% to $523.0 million in 2023, then decreased by 29.25% to $370.1 million in 2024, then plummeted by 37.13% to $232.7 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $232.7 million, $219.4 million, and $212.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.